Application of Benchtop NMR for Metabolomics Study Using Feces of Mice with DSS-Induced Colitis
暂无分享,去创建一个
T. Aizawa | H. Kumeta | T. Ayabe | Kiminori Nakamura | Jiaxi Jiang | Y. Kumaki | Zhiyan Hu | Zihao Song | Y. Yokoi | Yuki Ohnishi | Li Gan | Seiji Osada | Kazuo Yamauchi
[1] Jana M. Braunger,et al. Metabolomic profiles predict individual multidisease outcomes , 2022, Nature Medicine.
[2] S. Kuhn,et al. Computational Simulation of 1 H NMR Profiles of Complex Biofluid Analyte Mixtures at Differential Operating Frequencies: Applications to Low-Field Benchtop Spectra. , 2021, Magnetic resonance in chemistry : MRC.
[3] J. L. Izquierdo-García,et al. Benchtop nuclear magnetic resonance-based metabolomic approach for the diagnosis of bovine tuberculosis. , 2021, Transboundary and emerging diseases.
[4] D. Holland,et al. Quantitative analysis of wine and other fermented beverages with benchtop NMR. , 2021, Analytica chimica acta.
[5] R. Brüschweiler,et al. DEEP picker is a deep neural network for accurate deconvolution of complex two-dimensional NMR spectra , 2021, Nature Communications.
[6] M. Spraul,et al. Incomplete Systemic Recovery and Metabolic Phenoreversion in Post-Acute-Phase Nonhospitalized COVID-19 Patients: Implications for Assessment of Post-Acute COVID-19 Syndrome , 2021, Journal of proteome research.
[7] P. Lakatos,et al. The burden of inflammatory bowel disease in Europe in 2020. , 2021, Journal of Crohn's & colitis.
[8] K. Clément,et al. Gut microbiota-derived metabolites as central regulators in metabolic disorders , 2020, Gut.
[9] J. L. Izquierdo-García,et al. Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker , 2020, Scientific Reports.
[10] M. Grootveld,et al. Low-Field Benchtop NMR Spectroscopy as a Potential Non-Stationary Tool for Point-of-Care Urinary Metabolite Tracking in Diabetic Conditions. , 2020, Diabetes research and clinical practice.
[11] E. von Harbou,et al. Bayesian approach for automated quantitative analysis of benchtop NMR data. , 2020, Journal of magnetic resonance.
[12] S. Engelsen,et al. Human faecal 1H-NMR metabolomics: Evaluation of solvent and sample processing on coverage and reproducibility of signature metabolites. , 2020, Analytical chemistry.
[13] F. Casanova,et al. Benchtop Low-Frequency 60 MHz NMR Analysis of Urine: A Comparative Metabolomics Investigation , 2020, Metabolites.
[14] T. Aizawa,et al. Disease progression-associated alterations in fecal metabolites in SAMP1/YitFc mice, a Crohn’s disease model , 2020, Metabolomics.
[15] H. Sokol,et al. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease , 2020, Nature Reviews Gastroenterology & Hepatology.
[16] C. Cobas. NMR signal processing, prediction, and structure verification with machine learning techniques , 2020, Magnetic resonance in chemistry : MRC.
[17] L. Tenori,et al. Uniqueness of the NMR approach to metabolomics , 2019, TrAC Trends in Analytical Chemistry.
[18] T. H. Nguyen,et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The lancet. Gastroenterology & hepatology.
[19] Q. Liao,et al. A holistic view of gallic acid-induced attenuation in colitis based on microbiome-metabolomics analysis. , 2019, Food & function.
[20] D. Wishart,et al. NMR Spectroscopy for Metabolomics Research , 2019, Metabolites.
[21] Matthew B. Scholz,et al. Multi-Omic Analysis of the Microbiome and Metabolome in Healthy Subjects Reveals Microbiome-Dependent Relationships Between Diet and Metabolites , 2019, Front. Genet..
[22] Colin J. Brislawn,et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.
[23] K. Faber,et al. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases , 2019, Front. Immunol..
[24] F. Casanova,et al. Progress in low-field benchtop NMR spectroscopy in chemical and biochemical analysis. , 2019, Analytica chimica acta.
[25] Olivier Gonçalves,et al. Benchtop NMR for the monitoring of bioprocesses , 2019, Magnetic resonance in chemistry : MRC.
[26] Y. Shao,et al. Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease , 2019, Molecular Neurodegeneration.
[27] C. Huttenhower,et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease , 2018, Nature Microbiology.
[28] F. Casanova,et al. Low-Field, Benchtop NMR Spectroscopy as a Potential Tool for Point-of-Care Diagnostics of Metabolic Conditions: Validation, Protocols and Computational Models , 2018, High-throughput.
[29] B. Blümich,et al. Desktop NMR and Its Applications From Materials Science To Organic Chemistry. , 2018, Angewandte Chemie.
[30] B. Blümich,et al. Compact low-field NMR spectroscopy and chemometrics: A tool box for quality control of raw rubber , 2018 .
[31] G. Remaud,et al. High-throughput authentication of edible oils with benchtop Ultrafast 2D NMR. , 2018, Food chemistry.
[32] S. Tsuneda,et al. Meta-Analysis of Fecal Microbiota and Metabolites in Experimental Colitic Mice during the Inflammatory and Healing Phases , 2017, Nutrients.
[33] K. Kharbanda,et al. Dextran sodium sulfate colitis murine model: An indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis , 2017, World journal of gastroenterology.
[34] R. Gerszten,et al. The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease. , 2016, Journal of the American College of Cardiology.
[35] N. Leadbeater,et al. A benchtop NMR spectrometer as a tool for monitoring mesoscale continuous-flow organic synthesis: equipment interface and assessment in four organic transformations , 2016 .
[36] Caroline H. Johnson,et al. Metabolomics: beyond biomarkers and towards mechanisms , 2016, Nature Reviews Molecular Cell Biology.
[37] Wei Jia,et al. Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanism and Application of Metabolomics , 2016, International journal of molecular sciences.
[38] Ian D Wilson,et al. An overview of fecal sample preparation for global metabolic profiling. , 2015, Journal of pharmaceutical and biomedical analysis.
[39] Harry J. Flint,et al. The gut microbiota, bacterial metabolites and colorectal cancer , 2014, Nature Reviews Microbiology.
[40] U. Günther,et al. Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals , 2014, Metabolomics.
[41] Bernhard Blümich,et al. Miniaturization of NMR systems: desktop spectrometers, microcoil spectroscopy, and "NMR on a chip" for chemistry, biochemistry, and industry. , 2014, Chemical reviews.
[42] J. Paul,et al. Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India. , 2013, World journal of gastroenterology.
[43] Timothy L. Tickle,et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment , 2012, Genome Biology.
[44] Hans J. Vogel,et al. Quantitative Metabolomic Profiling of Serum, Plasma, and Urine by 1H NMR Spectroscopy Discriminates between Patients with Inflammatory Bowel Disease and Healthy Individuals , 2012, Journal of proteome research.
[45] T. Azuma,et al. GCMS‐based metabolomic study in mice with colitis induced by dextran sulfate sodium , 2011, Inflammatory bowel diseases.
[46] G. Kollias,et al. Metabolic phenotyping of the Crohn's disease-like IBD etiopathology in the TNF(ΔARE/WT) mouse model. , 2011, Journal of proteome research.
[47] E. K. Kemsley,et al. Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. , 2011, Journal of proteome research.
[48] T. Takenawa,et al. GC/MS-based profiling of amino acids and TCA cycle-related molecules in ulcerative colitis , 2011, Inflammation Research.
[49] H. Vogel,et al. Quantitative metabolomic profiling of serum and urine in DSS-induced ulcerative colitis of mice by (1)H NMR spectroscopy. , 2010, Journal of proteome research.
[50] G. Hwang,et al. 1H NMR-based metabonomic assessment of probiotic effects in a colitis mouse model , 2010, Archives of pharmacal research.
[51] A. Abdulamir,et al. The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects , 2010, The open biochemistry journal.
[52] J. Jansson,et al. Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease , 2009, PloS one.
[53] Dirk Haller,et al. Metabolic assessment of gradual development of moderate experimental colitis in IL-10 deficient mice. , 2009, Journal of proteome research.
[54] U. Sharma,et al. Metabolism of the colonic mucosa in patients with inflammatory bowel diseases: an in vitro proton magnetic resonance spectroscopy study. , 2009, Magnetic resonance imaging.
[55] H. Ogata,et al. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. , 2008, International journal of medical microbiology : IJMM.
[56] T. Ebbels,et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts , 2007, Nature Protocols.
[57] M. Neurath,et al. Mouse models of inflammatory bowel disease. , 2007, Advanced drug delivery reviews.
[58] I. Wilson,et al. Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. , 2007, Journal of proteome research.
[59] Ray L Somorjai,et al. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease , 2001, American Journal of Gastroenterology.